EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS023-15522 
Organism
Homo sapiens 
Tissue/cell
CD8+ 
Coordinate
chr2:231360900-231362970 
TF binding sites/motifs
Number: 34             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr2:231362158-231362176GGAAGGAGGAAAGGATGA+6.19
EWSR1-FLI1MA0149.1chr2:231362170-231362188GGATGAAGGGAAGGAGGG+6.19
EWSR1-FLI1MA0149.1chr2:231362134-231362152AGAGGGAAGGAGGGAAGG+6.55
EWSR1-FLI1MA0149.1chr2:231362126-231362144GGAGGGAAAGAGGGAAGG+6.56
EWSR1-FLI1MA0149.1chr2:231362146-231362164GGAAGGATGAAGGGAAGG+6.5
EWSR1-FLI1MA0149.1chr2:231362130-231362148GGAAAGAGGGAAGGAGGG+7.36
EWSR1-FLI1MA0149.1chr2:231362138-231362156GGAAGGAGGGAAGGATGA+7.53
ZNF263MA0528.1chr2:231362127-231362148GAGGGAAAGAGGGAAGGAGGG+6.07
ZNF263MA0528.1chr2:231362175-231362196AAGGGAAGGAGGGGAGGGGAG+6.09
ZNF263MA0528.1chr2:231362176-231362197AGGGAAGGAGGGGAGGGGAGG+6.12
ZNF263MA0528.1chr2:231362150-231362171GGATGAAGGGAAGGAGGAAAG+6.13
ZNF263MA0528.1chr2:231362170-231362191GGATGAAGGGAAGGAGGGGAG+6.23
ZNF263MA0528.1chr2:231362194-231362215AGGGGAGGGGAGGAGAGGAGA+6.23
ZNF263MA0528.1chr2:231362207-231362228AGAGGAGAGGAGAGGAGAGGA+6.37
ZNF263MA0528.1chr2:231362212-231362233AGAGGAGAGGAGAGGAGAGGA+6.37
ZNF263MA0528.1chr2:231362217-231362238AGAGGAGAGGAGAGGAGAGGA+6.37
ZNF263MA0528.1chr2:231362222-231362243AGAGGAGAGGAGAGGAGAGGA+6.37
ZNF263MA0528.1chr2:231362227-231362248AGAGGAGAGGAGAGGAGAGGA+6.37
ZNF263MA0528.1chr2:231362232-231362253AGAGGAGAGGAGAGGAGAGGA+6.37
ZNF263MA0528.1chr2:231362237-231362258AGAGGAGAGGAGAGGAGAGGA+6.37
ZNF263MA0528.1chr2:231362242-231362263AGAGGAGAGGAGAGGAGAGGA+6.37
ZNF263MA0528.1chr2:231362199-231362220AGGGGAGGAGAGGAGAGGAGA+6.42
ZNF263MA0528.1chr2:231362189-231362210AGGGGAGGGGAGGGGAGGAGA+6.63
ZNF263MA0528.1chr2:231362139-231362160GAAGGAGGGAAGGATGAAGGG+6.73
ZNF263MA0528.1chr2:231362184-231362205AGGGGAGGGGAGGGGAGGGGA+6.91
ZNF263MA0528.1chr2:231362159-231362180GAAGGAGGAAAGGATGAAGGG+6.94
ZNF263MA0528.1chr2:231362135-231362156GAGGGAAGGAGGGAAGGATGA+6
ZNF263MA0528.1chr2:231362202-231362223GGAGGAGAGGAGAGGAGAGGA+7.19
ZNF263MA0528.1chr2:231362123-231362144TGAGGAGGGAAAGAGGGAAGG+7.1
ZNF263MA0528.1chr2:231362167-231362188AAAGGATGAAGGGAAGGAGGG+7.22
ZNF263MA0528.1chr2:231362179-231362200GAAGGAGGGGAGGGGAGGGGA+8.15
ZNF263MA0528.1chr2:231361186-231361207GGAGGAGGAGAAGGAAGTGGA+8.16
ZNF263MA0528.1chr2:231362147-231362168GAAGGATGAAGGGAAGGAGGA+8.29
ZNF263MA0528.1chr2:231361183-231361204GGAGGAGGAGGAGAAGGAAGT+8.67
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_10885chr2:231355979-231366155CD20
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr2231361400231362071
chr2231361609231361691
Number: 1             
IDChromosomeStartEnd
GH02I230496chr2231361248231362698
Enhancer Sequence
AAGTCTAAGC AGAAATCACA TTTATTCCTT CTACTTCCTT TTCAAACCTG TTCTCTCAAA 60
TAGTTCTTTT CTTGCCAATG GATGAAGTCT TAGGTAAGCC CTAGAGCTAT GCTAGTCCCT 120
TTTAGCGGTA ATATCTCATT TAATATTAAA AAGCGTGAGC TGATATAATA TTAAAACTGG 180
AAATTATGTG GTAGGGAAGC TGGGTGAAGT CAGCATTTAC TTTCATCCAC ACTTCCTCTC 240
CAACTCCACT CAGTGTCTAT TGCTTTCAGC TAATTTGGGT CTAGGAGGAG GAGGAGAAGG 300
AAGTGGACAG GAGCAGGAAT GGTCCTCATA CTATATAGGT TGGTGCAAAA GTAATTGTGG 360
GTTTTGCCTT TTAAAAAAAA AGGGAATAGC AAAAACTGCA ATTACTTTTG CACCAACCTT 420
ATAGATTTTG GTGTCTCCTA GATATGGTGG ATGCATGAGC CATATTCATT TGTGAGTTCT 480
TCAGAGACAC TCAACTTAGA GAGAACCTCT CAACCAAAGT TCCCCTAATT CAGGAACTTC 540
AACTGGATGC TTACCAATTC CCTCAGTCTC CCAGCTCTGG GAGGTCCACA CTACACTCCT 600
GCTGGGGTCA ACTCATCCAT CCAAGTGATT CTCCCAGACA GAATATCTCT CAAGAAGAAC 660
TAAGTGAGTT CCTCCTTTCC CTAGGGAGAC CTATAGGAAT TATGACTCTT CATACCCTCT 720
CAACATTCTA GGATTGAGTC TATAAATGTC TCTGCCTTCC TCAAACTCCT GAAGGTGAAG 780
ATCAGTTACA TTGAAACTGA AGTCTTCTCA GTTGCCTTAA GGACGGAGGA GCACTTTACT 840
CAACTTCTAT AACATGGTGT TAACCTTTAG TATTTGGGTA GGAAATCCAA GAATAGCCAC 900
ACTACTTCCT GTGGGGTATT TGAGCAAGAC AATTTGCAAA GAATAATTAC AAAGGAAGTC 960
CCAAGAGCTC TATAGTATTA GCAGATCTTA AGCCCCAAAT CTTCTAGTAA GTAGAGCTCG 1020
AGTAAACGGA ACTAAACTAC TTGTATACCT CTAATTTGTT TGTCCTCAGT GGACTTTGAT 1080
GAAAGGTGAC TACAACAGGA CCAAAGACAT AGATGAACAG AAAAAGAGTC TTTGTTTGTC 1140
TAAGATATTT ATGGTTGGAC AAGTTCAAAT TGTGGCCAGG CCATATAAAG AAAGAAAGGA 1200
AAGAAAAATG CAGGGAGATG GTGTGAGGAG GGAAAGAGGG AAGGAGGGAA GGATGAAGGG 1260
AAGGAGGAAA GGATGAAGGG AAGGAGGGGA GGGGAGGGGA GGGGAGGAGA GGAGAGGAGA 1320
GGAGAGGAGA GGAGAGGAGA GGAGAGGAGA GGAGAGGAGA GGAAAGGAAA GGAAAGGAAA 1380
GGAAAGGAAA GGAAAGGAAA GGAAAGGAAA GGAAAGGAAA GGAAAGGAAA GGATCAGCAC 1440
CTTTAAACAT GGCACTCATG AGATGCTCCT GCACATACCT CACTGTCTTT CTACCTACCC 1500
CCATCACCTG CTGAATCTAA CAGCATATTC CTGAAATAGG GTTTTAATCA ACCCTTTGTT 1560
AGTCCTAACC CTAAGGCTTT CTGGGACTTG AATCTCTATA CAAATTCCCC TTGGACAATA 1620
ATCTCTTGGT TAGTTTCTTA GATCCTAATT TTTTGGCCAA ACCTATGTGA ATAAGGTCTT 1680
TGGTCATTTT CACTGTATTT TCAGCCTCAA AGCCTTCATT GAGGGCTAAG ATGGTGGCTA 1740
GTGTGTCACC ATCATAATGA GCAGGACAAT CCAAATTCTT GCATTGCTGC CATTGATTTC 1800
TGCCTACAAC CAGAGGAAAT CTGCAATGCT TCACTTCATT TTGCAATATC TGTATGCTGA 1860
AGTTTCTTCA TTGGTCATAG GGGTAGTAAA AGTCTCTATC TCATAAATGA ATTAGTAGAT 1920
GTAAATATCT TGTGTTAGTG TCTAGCACAT AATAAGCACT TAAGTCTTAG CCCTCATTAT 1980
TATTATTCTT ACAGTATTCT TTGGGATATA AATGAAACTG TCGTAAATTC TTTTTAAAAT 2040
TAATGTTGGG GGGAGGCAAA TGAATTTGGA 2070